Mirum Pharmaceuticals Inc
MIRM
Market Cap$2.16B
Close$
$27.50
39.2% downside
Current Fair Value
39.2% downsideOvervalued by 39.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.16 Billion |
|---|---|
| Enterprise Value | $2.26 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.85 |
| Beta | 1.01 |
| Outstanding Shares | 48,338,096 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -24.01 |
|---|---|
| PEG | 60.56 |
| Price to Sales | 7.54 |
| Price to Book Ratio | 11.31 |
| Enterprise Value to Revenue | 7.35 |
| Enterprise Value to EBIT | -25.62 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 1.41 |
Revenue Sources
No data
Insider Trades
ESG Score
No data